Clinical trialNCT06966024RecruitingPhase 1Interventional

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

SponsorDeciphera Pharmaceuticals, LLCEnrollment60Castration-resistant Prostate CancerRenal Cell CarcinomaUrothelial Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Clinical Team
Deciphera Pharmaceuticals, LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Bicky Thapa, MD
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Ulka Vaishampayan, MD
Recruiting
Vanderbilt- Ingram Cancer Center
Nashville, Tennessee, United States
Brian Rini, MD
Recruiting
Next Oncology, Austin
Austin, Texas, United States
Andrae Vandross, MD
Recruiting
Next Oncology, San Antonio
San Antonio, Texas, United States
Ildefonso Rodriguez Rivera, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DCC-2812

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Aug 2025
Primary completion: 28 Feb 2029
Completion: 28 Feb 2029
Last update posted: 20 May 2026
Registered enrollment: 60
Registry id: NCT06966024

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.